Brief: Xspray Pharma To Advance Fourth Product Candidate XS015 Into Clinical Trials

Xspray Pharma publ AB

22/04/2024 15:17

April 22 (Reuters) - XSpray Pharma AB (publ)
 XSPRAY.ST :
    * STRATEGIC DECISION TO ADVANCE ITS FOURTH PRODUCT CANDIDATE
XS015
INTO CLINICAL TRIALS
    * IS CURRENTLY IN FINAL PHASE OF PREPARATION FOR ANTICIPATED
LAUNCH OF ITS FIRST PRODUCT, DASYNOCTM, ON SEPTEMBER 1, 2024
PENDING FINAL FDA APPROVAL

Source text for Eikon:  ID:nMFN5x19tq 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))